arrow_back Back to App

Universal Flu Vaccine Research: New Funding for Public Health

This act allocates funds for intensive research into creating a universal influenza vaccine or preventative. The goal is to improve public health and reduce the threat of seasonal illnesses, potentially leading to fewer infections and better well-being for citizens.
Key points
Allocating $200 million annually for universal flu vaccine research from 2022 to 2026.
Directing the National Institute of Allergy and Infectious Diseases to lead research for lasting flu protection.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_3258
Sponsor: Sen. Markey, Edward J. [D-MA]
Process start date: 2021-11-18
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Flu Vaccine Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_3258.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-11-18.

What are the main provisions?

Key points include:

  • Allocating $200 million annually for universal flu vaccine research from 2022 to 2026.
  • Directing the National Institute of Allergy and Infectious Diseases to lead research for lasting flu protection.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Markey, Edward J. [D-MA].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health Public Investments